Home Healthcare Pharmaceuticals Acute Myeloid Leukemia Treatment Market

Acute Myeloid Leukemia Treatment Market Size, Share & Trends Analysis Report By Type (Myeloblastic, Promyelocytic, Myelomonocytic, Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Acute Myeloid Leukemia Treatment Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Myeloblastic
    2. Promyelocytic
    3. Myelomonocytic
    4. Others
  2. Acute Myeloid Leukemia Treatment Market, By Treatment Type 2022-2034 (USD MILLION/ Units)
    1. Chemotherapy
    2. Targeted Therapy
    3. Immunotherapy
    4. Stem Cell Transplantation
    5. Others
  3. Acute Myeloid Leukemia Treatment Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Intravenous
    3. Subcutaneous
  4. Acute Myeloid Leukemia Treatment Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Specialty Clinics
    4. Online Pharmacies
  5. Regional Acute Myeloid Leukemia Treatment Market
    1. North America
      1. North America Acute Myeloid Leukemia Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
      2. North America Acute Myeloid Leukemia Treatment Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Stem Cell Transplantation
        5. Others
      3. North America Acute Myeloid Leukemia Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Subcutaneous
      4. North America Acute Myeloid Leukemia Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Specialty Clinics
        4. Online Pharmacies
      5. U.S.
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      6. Canada
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
    2. Europe
      1. Europe Acute Myeloid Leukemia Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
      2. Europe Acute Myeloid Leukemia Treatment Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Stem Cell Transplantation
        5. Others
      3. Europe Acute Myeloid Leukemia Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Subcutaneous
      4. Europe Acute Myeloid Leukemia Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Specialty Clinics
        4. Online Pharmacies
      5. U.K.
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      6. Germany
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      7. France
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      8. Spain
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      9. Italy
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      10. Russia
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      11. Nordic
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      12. Benelux
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      13. Rest of Europe
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
    3. APAC
      1. APAC Acute Myeloid Leukemia Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
      2. APAC Acute Myeloid Leukemia Treatment Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Stem Cell Transplantation
        5. Others
      3. APAC Acute Myeloid Leukemia Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Subcutaneous
      4. APAC Acute Myeloid Leukemia Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Specialty Clinics
        4. Online Pharmacies
      5. China
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      6. Korea
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      7. Japan
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      8. India
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      9. Australia
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      10. Singapore
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      11. Taiwan
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      12. South East Asia
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      13. Rest of Asia-Pacific
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Acute Myeloid Leukemia Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
      2. Middle East and Africa Acute Myeloid Leukemia Treatment Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Stem Cell Transplantation
        5. Others
      3. Middle East and Africa Acute Myeloid Leukemia Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Subcutaneous
      4. Middle East and Africa Acute Myeloid Leukemia Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Specialty Clinics
        4. Online Pharmacies
      5. UAE
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      6. Turkey
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      7. Saudi Arabia
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      8. South Africa
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      9. Egypt
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      10. Nigeria
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      11. Rest of MEA
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
    5. LATAM
      1. LATAM Acute Myeloid Leukemia Treatment Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
      2. LATAM Acute Myeloid Leukemia Treatment Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Targeted Therapy
        3. Immunotherapy
        4. Stem Cell Transplantation
        5. Others
      3. LATAM Acute Myeloid Leukemia Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Subcutaneous
      4. LATAM Acute Myeloid Leukemia Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Specialty Clinics
        4. Online Pharmacies
      5. Brazil
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      6. Mexico
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      7. Argentina
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      8. Chile
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      9. Colombia
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
      10. Rest of LATAM
        1. Myeloblastic
        2. Promyelocytic
        3. Myelomonocytic
        4. Others
        5. Chemotherapy
        6. Targeted Therapy
        7. Immunotherapy
        8. Stem Cell Transplantation
        9. Others
        10. Oral
        11. Intravenous
        12. Subcutaneous
        13. Hospital Pharmacies
        14. Retail Pharmacies
        15. Specialty Clinics
        16. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.